إعلان
إعلان
SNOA
Sonoma Pharmaceuticals, Inc. Common Stock
3.67
USDبرعاية
-0.10
-2.78%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
3.56
-0.11
-2.99%
تقارير أرباح SNOA
النسبة الإيجابية المفاجئة
SNOA تفوق 11 من 21 آخر التقديرات.
52%
التقرير التالي
بيانات التقرير القادم
٠٣ فبراير ٢٠٢٦
Estimate for Q3 26 (Revenue/ EPS)
$4.41M
/-$0.31
التغير الضمني من Q2 26 (Revenue/ EPS)
-21.26%
/-3.13%
التغير الضمني من Q3 25 (Revenue/ EPS)
+23.81%
/-50.79%
Sonoma Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, SNOA reported earnings of -0.32 USD per share (EPS) for Q2 26, missing the estimate of -0.31 USD, resulting in a -1.20% surprise. Revenue reached 5.60 مليون, compared to an expected 4.35 مليون, with a 28.94% difference. The market reacted with a -0.53% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 المحللين forecast an EPS of -0.31 USD, with revenue projected to reach 4.41 مليون USD, implying an نقصان of -3.13% EPS, and نقصان of -21.26% in Revenue from the last quarter.
الأسئلة الشائعة
What were Sonoma Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Sonoma Pharmaceuticals, Inc. Common Stock reported EPS of -$0.32, missing estimates by -1.2%, and revenue of $5.60M, 28.94% above expectations.
How did the market react to Sonoma Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -0.53%, changed from $3.78 before the earnings release to $3.76 the day after.
When is Sonoma Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٣ فبراير ٢٠٢٦.
What are the forecasts for Sonoma Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 3
المحللين, Sonoma Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.31 and revenue of $4.41M for Q3 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان